(back)
 
Immediate Release

To All Attorney Generals

June 7, 2007

Marianne Skolek www.oxydeaths.com

In the matter of Purdue Pharma paying $600 million in fines and other payments for the criminal charge of misbranding their product OxyContin and the Federal Drug Administration being unresponsive as shown below, please convene a review panel to review the FDA's involvement in the criminal activities of Purdue Pharma in their marketing of OxyContin:

Whereas; in a statement issued May 10, 2007 by Attorney General Richard Blumenthal of Connecticut regarding the criminal charges against Purdue Pharma, he states:

"The FDA has yet to act on our Citizen Petition more than three years after my office filed it. The FDA's glaring and galling failure to act demonstrates the need for wide-ranging reform of the FDA."

Whereas; my emails to the following people in the FDA come back to me as "deleted and unread":

thomas.abrams@fda.hhs.gov

margaret.glavin@fda.hhs.gov

david.graham@fda.hhs.gov

It is herein requested that immediate action be taken against the FDA to determine why they never required Purdue Pharma to put the word "addictive" on their label when thousands of victims were dying and becoming addicted to the drug.

It is herein requested that an investigation be conducted as to Curtis Wright's role in approving OxyContin while employed by the FDA and then being employed by Purdue Pharma.

It is herein requested that as Attorney General Blumenthal stated there be a wide range of reform of the FDA in light of the seriousness of the problem with OxyContin as well as other drugs recently in the news and approved by the FDA with life threatening and serious consequences to individuals taking the drugs.

Marianne Skolek

(back)